Dietzschold B - Search Results

1

Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic.

McGettigan JP, Pomerantz RJ, Siler CA, McKenna PM, Foley HD, Dietzschold B, Schnell MJ. McGettigan JP, et al. Among authors: dietzschold b. J Virol. 2003 Jan;77(1):237-44. doi: 10.1128/jvi.77.1.237-244.2003. J Virol. 2003. PMID: 12477829 Free PMC article.

2

Recombinant rabies virus as potential live-viral vaccines for HIV-1.

Schnell MJ, Foley HD, Siler CA, McGettigan JP, Dietzschold B, Pomerantz RJ. Schnell MJ, et al. Among authors: dietzschold b. Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3544-9. doi: 10.1073/pnas.97.7.3544. Proc Natl Acad Sci U S A. 2000. PMID: 10706640 Free PMC article.

3

Reinvestigation of the role of the rabies virus glycoprotein in viral pathogenesis using a reverse genetics approach.

Morimoto K, Foley HD, McGettigan JP, Schnell MJ, Dietzschold B. Morimoto K, et al. Among authors: dietzschold b. J Neurovirol. 2000 Oct;6(5):373-81. doi: 10.3109/13550280009018301. J Neurovirol. 2000. PMID: 11031690

4

A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection.

Foley HD, McGettigan JP, Siler CA, Dietzschold B, Schnell MJ. Foley HD, et al. Among authors: dietzschold b. Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14680-5. doi: 10.1073/pnas.011510698. Proc Natl Acad Sci U S A. 2000. PMID: 11114165 Free PMC article.

5

High level expression of a human rabies virus-neutralizing monoclonal antibody by a rhabdovirus-based vector.

Morimoto K, Schnell MJ, Pulmanausahakul R, McGettigan JP, Foley HD, Faber M, Hooper DC, Dietzschold B. Morimoto K, et al. Among authors: dietzschold b. J Immunol Methods. 2001 Jun 1;252(1-2):199-206. doi: 10.1016/s0022-1759(01)00353-2. J Immunol Methods. 2001. PMID: 11334980

6

Genetic engineering of live rabies vaccines.

Morimoto K, McGettigan JP, Foley HD, Hooper DC, Dietzschold B, Schnell MJ. Morimoto K, et al. Among authors: dietzschold b. Vaccine. 2001 May 14;19(25-26):3543-51. doi: 10.1016/s0264-410x(01)00064-0. Vaccine. 2001. PMID: 11348722

7

Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity.

Pulmanausahakul R, Faber M, Morimoto K, Spitsin S, Weihe E, Hooper DC, Schnell MJ, Dietzschold B. Pulmanausahakul R, et al. Among authors: dietzschold b. J Virol. 2001 Nov;75(22):10800-7. doi: 10.1128/JVI.75.22.10800-10807.2001. J Virol. 2001. PMID: 11602721 Free PMC article.

8

Pathogenesis of rabies.

Dietzschold B, Schnell M, Koprowski H. Dietzschold B, et al. Curr Top Microbiol Immunol. 2005;292:45-56. doi: 10.1007/3-540-27485-5_3. Curr Top Microbiol Immunol. 2005. PMID: 15981467 Review.

9

Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine.

Dietzschold B, Gore M, Marchadier D, Niu HS, Bunschoten HM, Otvos L Jr, Wunner WH, Ertl HC, Osterhaus AD, Koprowski H. Dietzschold B, et al. J Virol. 1990 Aug;64(8):3804-9. doi: 10.1128/JVI.64.8.3804-3809.1990. J Virol. 1990. PMID: 1695255 Free PMC article.

10

Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures.

Morimoto K, Hooper DC, Spitsin S, Koprowski H, Dietzschold B. Morimoto K, et al. Among authors: dietzschold b. J Virol. 1999 Jan;73(1):510-8. doi: 10.1128/JVI.73.1.510-518.1999. J Virol. 1999. PMID: 9847357 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters